Samcro Hyosung Adilestari Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Samcro Hyosung Adilestari Tbk. trades at Rp64 (market cap 218.57B, 3.54M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp312 (market cap 821.5B, 25.58M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 3.8× Samcro Hyosung Adilestari Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.58M versus 3.54M). Which is the better fit depends on your goals.
| ACRO | RSCH | |
|---|---|---|
Market Cap | 218.57B | 821.5B |
Volume | 3.54M | 25.58M |
Lot | 35.44K | 255.79K |
Turnover | 226.15M | 7.95B |
Average Price | 63.81 | 310.76 |
Value | 226.15M | 7.95B |
Indicative Equilibrium Price | 63 | 312 |
Indicative Equilibrium Volume | 13.8K | 10 |
Trailing returns across standard periods
Latest headlines on both assets
PT Samcro Hyosung Adilestari Tbk (The Company) was established on Republic of Indonesia based on Deed of Establishment No. 265 dated July 21, 1989 by Yudo Paripurno, S.H., Notary in Jakarta.
Read more on ACRO →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →